- Home
- WVVI vs RVPH Comparison
WVVI vs RVPH Comparison
Compare WVVI & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVVI
- RVPH
- Stock Information
- Founded
- WVVI 1983
- RVPH 2006
- Country
- WVVI United States
- RVPH United States
- Employees
- WVVI N/A
- RVPH N/A
- Industry
- WVVI Beverages (Production/Distribution)
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- WVVI Consumer Staples
- RVPH Health Care
- Exchange
- WVVI Nasdaq
- RVPH Nasdaq
- Market Cap
- WVVI 28.2M
- RVPH 26.6M
- IPO Year
- WVVI N/A
- RVPH N/A
- Fundamental
- Price
- WVVI $4.85
- RVPH $0.46
- Analyst Decision
- WVVI
- RVPH Strong Buy
- Analyst Count
- WVVI 0
- RVPH 5
- Target Price
- WVVI N/A
- RVPH $9.00
- AVG Volume (30 Days)
- WVVI 6.3K
- RVPH 3.2M
- Earning Date
- WVVI 08-12-2025
- RVPH 08-13-2025
- Dividend Yield
- WVVI N/A
- RVPH N/A
- EPS Growth
- WVVI N/A
- RVPH N/A
- EPS
- WVVI N/A
- RVPH N/A
- Revenue
- WVVI $38,520,945.00
- RVPH N/A
- Revenue This Year
- WVVI N/A
- RVPH N/A
- Revenue Next Year
- WVVI N/A
- RVPH N/A
- P/E Ratio
- WVVI N/A
- RVPH N/A
- Revenue Growth
- WVVI N/A
- RVPH N/A
- 52 Week Low
- WVVI $3.17
- RVPH $0.30
- 52 Week High
- WVVI $7.18
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- WVVI 37.97
- RVPH 46.82
- Support Level
- WVVI $4.78
- RVPH $0.44
- Resistance Level
- WVVI $4.95
- RVPH $0.53
- Average True Range (ATR)
- WVVI 0.17
- RVPH 0.04
- MACD
- WVVI -0.00
- RVPH 0.02
- Stochastic Oscillator
- WVVI 22.16
- RVPH 56.07
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.